Short Interest in Enfusion, Inc. (NYSE:ENFN) Declines By 22.4%

Enfusion, Inc. (NYSE:ENFN - Get Free Report) saw a large drop in short interest during the month of October. As of October 31st, there was short interest totalling 1,180,000 shares, a drop of 22.4% from the October 15th total of 1,520,000 shares. Currently, 2.4% of the company's shares are sold short. Based on an average daily volume of 381,300 shares, the days-to-cover ratio is currently 3.1 days.

Enfusion Stock Up 0.1 %

Shares of ENFN stock traded up $0.01 on Friday, reaching $9.89. 475,071 shares of the stock were exchanged, compared to its average volume of 381,076. Enfusion has a 1-year low of $7.52 and a 1-year high of $10.45. The stock has a market cap of $1.27 billion, a P/E ratio of 247.50, a price-to-earnings-growth ratio of 3.62 and a beta of 0.93. The firm has a 50 day moving average of $8.93 and a two-hundred day moving average of $8.85.

Institutional Investors Weigh In On Enfusion

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. TenCore Partners LP acquired a new stake in Enfusion during the 3rd quarter worth approximately $3,938,000. Dimensional Fund Advisors LP grew its stake in Enfusion by 57.5% during the second quarter. Dimensional Fund Advisors LP now owns 524,142 shares of the company's stock worth $4,466,000 after buying an additional 191,436 shares during the period. Impax Asset Management Group plc increased its position in shares of Enfusion by 25.4% in the third quarter. Impax Asset Management Group plc now owns 676,948 shares of the company's stock worth $6,424,000 after acquiring an additional 136,948 shares in the last quarter. Scalar Gauge Management LLC raised its stake in shares of Enfusion by 21.8% in the 2nd quarter. Scalar Gauge Management LLC now owns 613,513 shares of the company's stock valued at $5,227,000 after acquiring an additional 110,000 shares during the period. Finally, SG Americas Securities LLC acquired a new position in shares of Enfusion during the 3rd quarter valued at $892,000. 81.05% of the stock is currently owned by institutional investors and hedge funds.

Enfusion Company Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.